Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.06B |
| Enterprise Value | 10.05B |
| P/E Ratio | 17.51 |
| PEG Ratio | 4.66 |
| Price/Sales Ratio | 2.61 |
| Price/Book Ratio | 2.27 |
| Enterprise/Revenue | 2.53 |
| Enterprise/EBITDA | 13.34 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.17 |
AD
Management Effectiveness
| Return On Assets | 0.11 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 3.87B |
| Revenue/Share | 9.26 |
| Gross Profit | 1.9B |
| EBITDA | 810.78M |
| Net Income | 581.49M |
| Diluted EPS | 1.35 |
Balance Sheet
| Total Cash | 2.52B |
| Total Cash/Share | 5.84 |
| Total Debt | 245.77M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 4.65 |
| Book Value Per Share | 10.96 |
Price History
| 52-Week Change | -18.18 |
| 52-Week High | 30.18 |
| 52-Week Low | 21.22 |
| Moving Average 50 Days | 23.36 |
| Moving Average 200 Days | 24.44 |
Statistics
| Average Volume | 5.09M |
| Shares Outstanding | 431.05M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.7 |
| Trailing Annual Dividend Yield | 2.9 |
| Payout Ratio | 0.51 |
| Last Split Factor | 13:10 |
| Last Split Date | July 21, 2015 |
AD
